ASCO’s new clinical insights on Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma
ASCO (American Society of Clinical Oncology) shared a post on LinkedIn about a recent paper by Van Morris et al. published in JCO Oncology Practice:
“Check out our new clinical insights on Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma. Learn more.”
“Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline Clinical Insights”
Authors: Van Morris, Jennifer Dorth, Erin Kennedy, Cathy Eng.
More posts featuring ASCO.
The American Society of Clinical Oncology (ASCO) is a leading professional organization representing nearly 45,000 physicians and oncology specialists worldwide, dedicated to cancer care.
Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, ASCO is committed to advancing cancer research, education, prevention, and high-quality patient care.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023